trial

Bifrontal and Bitemporal Electroconvulsive Therapy (ECT) in Treatment of Patients With Schizophrenia

NCTId NCT02511509
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 100 (estimated)
Sponsored by Medical University of Lodz
Primary completion 2018-07
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
100 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2015-09
Primary completion
2018-07
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Bifrontal electroconvulsive therapyBitemporal electroconvulsive therapy

Sponsors

Medical University of LodzLead Sponsor

Investigators

1
Iwona Kloszewska, Prof.Principal Investigator

Sites

1 total
Lodz, Poland

Facts & assertions

4 sourced
Enrollment
100
Phase
NA
Primary Completion Date
2018-07
Status
UNKNOWN
relationships
The graph out of here
drug
Bifrontal electroconvulsive therapy
drug
Bitemporal electroconvulsive therapy
drug
lead_sponsor
Medical University of Lodz
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Iwona Kloszewska, Prof.
person